Researchers at the National Institutes of Health (NIH) found previously undetected cancers in 48.6% of pregnant people who had abnormal results for prenatal cell-free DNA (cfDNA) testing used to ...

Blood cancer impairs the bone marrow's ability to produce healthy blood cells. While these cancers are serious, the growing knowledge in medical science has improved survival rates. Understanding the ...

A rare form of leukemia known as TCF3::HLF-positive B cell acute lymphoblastic leukemia (B-ALL) sits among the most aggressive blood cancers seen in children. The disease causes a rapid buildup of ...

CHICAGO (Reuters) - Older patients whose red blood cell counts are even slightly out of the normal range are at higher risk of death and heart problems after major surgery, U.S. researchers said on ...

Acute myeloid leukemia (AML) is a type of blood and bone marrow cancer. AML can affect people of any age, but it is most common in adults. AML occurs when bone marrow produces abnormal blood cells, ...

An AI tool that can analyze abnormalities in the shape and form of blood cells, and with greater accuracy and reliability than human experts, could change the way conditions such as leukemia are ...

Trained on one of the largest blood smear datasets ever, a new AI tool can flag disease signs and assist clinicians in a way never seen before. Researchers at the University of Cambridge developed the ...

A genetic risk score can help predict which women will develop invasive breast cancer after abnormal cells have been found in their breast tissue, researchers said. Women who scored high on the ...

Arteriovenous malformations, a hallmark of hereditary hemorrhagic telangiectasia, may be driven by endothelial cell-cycle acceleration via CDK6, suggesting potential for repurposing CDK6 inhibitors.

Rytelo (imetelstat) is a medicine used to treat myelodysplastic syndromes (MDS). MDS is a rare group of disorders that affect your blood cells. Most people who get MDS are 65 years of age or older, ...